HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis. [electronic resource]
Producer: 20180827Description: 1213-1215 p. digitalISSN:- 1445-5994
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Azathioprine -- therapeutic use
- Diabetes Mellitus, Type 2 -- drug therapy
- Fatal Outcome
- Female
- Hepatitis, Autoimmune -- drug therapy
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Myositis -- diagnostic imaging
- Prednisolone -- therapeutic use
- Renal Insufficiency, Chronic -- drug therapy
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.